Page 112 - 《中国药房》2023年24期
P. 112
不同肠内营养制剂用于重症急性胰腺炎的疗效及胃肠道耐受性
研究
Δ
陈 旭 ,邓 毅 ,李 强 ,吴 迪 (1.电子科技大学医学院附属妇女儿童医院/成都市妇女儿童中心医院药
1
1*
3 #
2
学部,成都 611731;2.江苏省人民医院胰腺中心,南京 210029;3.江苏省人民医院药学部,南京 210029)
中图分类号 R969.3 文献标志码 A 文章编号 1001-0408(2023)24-3046-05
DOI 10.6039/j.issn.1001-0408.2023.24.16
摘 要 目的 比较不同肠内营养(EN)制剂用于重症急性胰腺炎(SAP)患者的疗效和胃肠道耐受性。方法 收集 2022 年 1 月 1
日-2023年6月30日于江苏省人民医院胰腺中心住院治疗的118例SAP患者的临床资料,按使用EN制剂的不同分为短肽类EN
制剂(SP)组(41例)、不含膳食纤维的整蛋白EN制剂(TP-MCT)组(40例)和含膳食纤维的整蛋白EN制剂(TPF-DM)组(37例)。3
组患者均鼻饲24 h连续泵注EN制剂,能量目标量均为25~30 kcal/kg。收集3组患者用药前和用药7 d后的血液营养指标[白蛋白
(ALB)、总蛋白(TP)、血红蛋白(Hb)、球蛋白(GLB)]和炎症指标[白细胞(WBC)、中性粒细胞百分比(N%)、降钙素原(PCT)、C反
应蛋白(CRP)、白细胞介素6(IL-6)],并汇总其临床结局指标[入住重症监护室(ICU)时间、住院时长、恢复经口饮食时长、病情未
好转率、死亡率]及胃肠道耐受情况。结果 用药后,3组患者的ALB、TP均显著高于同组用药前(P<0.05);3组患者的CRP、N%,
TP-MCT组患者的PCT和SP组患者的IL-6均显著低于同组用药前,且TP-MCT组的PCT和SP组的IL-6均显著低于同期的其他
两组(P<0.05);3组间用药后ALB、TP、CRP、N%比较及3组用药前后的Hb、GLB、WBC比较,差异均无统计学意义(P>0.05)。3
组患者的临床结局指标比较,差异均无统计学意义(P>0.05)。TP-MCT组患者的胃肠道总不良反应发生率最低(32.50%),且显
著低于SP组(46.34%)和TPF-DM(48.65%)(P<0.05)。结论 不同EN制剂均能不同程度地改善SAP患者的营养状态并降低炎症
反应,其中SP和TP-MCT的疗效较显著,且后者的胃肠道耐受性较好。
关键词 肠内营养;重症急性胰腺炎;疗效;耐受性;不良反应
Efficacy of different enteral nutrition drugs for severe acute pancreatitis and their gastrointestinal tolerance
1
1
CHEN Xu ,DENG Yi ,LI Qiang ,WU Di(1. Dept. of Pharmacy, the Affiliated Women’s and Children’s
3
2
Hospital, School of Medicine, University of Electronic Science and Technology of China/Chengdu Women’s
and Children’s Central Hospital, Chengdu 611731, China;2. Pancreatic Center, Jiangsu Provincial People’s
Hospital, Nanjing 210029, China;3. Dept. of Pharmacy, Jiangsu Provincial People’s Hospital, Nanjing
210029, China)
ABSTRACT OBJECTIVE To compare the efficacy of different enteral nutrition (EN) drugs for severe acute pancreatitis (SAP)
and their gastrointestinal tolerance. METHODS A total of 118 SAP patients admitted to the Pancreatic Center of Jiangsu Provincial
People’s Hospital from January 1, 2022 to June 30, 2023 were collected and divided into short-peptide EN drugs (SP) group (41
cases), dietary fiber-free intact protein EN drugs (TP-MCT) group (40 cases) and dietary fiber-containing intact protein EN drugs
(TPF-DM) group (37 cases) according to the types of EN. All three groups of patients were given continuous pumps of EN drugs
via nasal feeding for 24 hours, with a target energy dose of 25-30 kcal/kg. The blood nutritional indexes [albumin (ALB), total
protein (TP), hemoglobin (Hb), globulin (GLB)], inflammation indexes [white blood cells (WBC), percentage of neutrophils
(N%), procalcitonin (PCT), C-reactive protein (CRP), interleukin-6 (IL-6)], clinical outcomes indexes [time of stay in the
intensive care unit (ICU), length of hospital stay, duration of resuming oral diet, the rate of cases without improvement, mortality
rate] and the occurrence of gastrointestinal tolerance were collected from 3 groups before medication and 7 d after medication.
RESULTS After treatment, ALB and TP in 3 groups were significantly higher than before treatment (P<0.05); CRP and N% of 3
groups, PCT of TP-MCT group and IL-6 of SP group were significantly lower than corresponding group before medication (P<
0.05); PCT of TP-MCT group and IL-6 of SP group were
Δ 基金项目 江苏省药学会-奥赛康医院药学基金(No.A202101) significantly lower than those of other two groups at
*第一作者 主管药师,硕士。研究方向:临床药学。E-mail:
corresponding period (P<0.05). There were no statistical
84646975@qq.com
# 通信作者 主 管 药 师 。 研 究 方 向 :临 床 药 学 。 E-mail: significances in ALB, TP, CRP or N% among the three
nanjingwudi@126.com groups after medication, and in Hb, GLB or WBC among the
· 3046 · China Pharmacy 2023 Vol. 34 No. 24 中国药房 2023年第34卷第24期